esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation is a research paper published in Molecular Therapy — Oncolytics (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Prevention and Research Institute of Texas
Grant: CPRIT RP210045
Cancer Prevention and Research Institute of Texas
Grant: R03 CA252770
American Cancer Society
Grant: R21 NS123685-01A1
American Cancer Society
Grant: RSG-19-185-01-MPC
U.S. Department of Defense
Grant: RP200615
National Institutes of Health
Grant: R01 CA150153
National Institutes of Health
Grant: R61NS112410
National Institutes of Health
Grant: P01CA163205-08
NINDS NIH HHS
Grant: R21 NS123685
NCI NIH HHS
Grant: P01 CA163205
National Institutes of Health
Grant: W81XWH-21-10068
Keywords